Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Therapy on Lipid Metabolism and Insulin Sensitivity in Hypogonadal Women
NCT07821086Active, not recruiting
- Sponsor
- Khyber Medical University
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial of estradiol valerate in female hypogonadism, sponsored by Khyber Medical University. Primary endpoints: Change in Lipid Profile at 3 months and Change in Insulin Sensitivity (HOMA-IR) at 3 months. Started Dec 2025; status: active, not recruiting.
02
Drugs
estradiol valerate
03
Conditions
female hypogonadism
Beyond the preview
Go deeper on NCT07821086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07821086.